Aileron Therapeutics Inc.

NASDAQ: ALRN
Share price (1/6/25): $2.09
Market cap (1/6/25): $45.3 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 103 pages Agreement and Plan of Merger by and Among Aileron Therapeutics, Inc. at Merger Sub I, Inc., at Merger Sub II, LLC and Lung Therapeutics, Inc. Dated as of October 31, 2023

from SC 13D/A 6 pages Merrill Lynch, Pierce, Fenner & Smith Incorporated Jefferies LLC as Representatives of the Several Underwriters to Be Named in the Within-Mentioned Underwriting Agreement C/O Merrill Lynch, Pierce, Fenner & Smith Incorporated One Bryant Park New York, New York 10036 and Jefferies LLC 520 Madison Avenue New York, New York 10022 Re: Proposed Public Offering by Aileron Therapeutics, Inc. Dear Sirs